Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: A comparative study

Lancet

Volumn 360, Issue 9343, 2002, Pages 1361-1368

  Klein, M ^a   Heimans, J J ^a   Aaronson, N K ^b   Van Der Ploeg, H M ^a   Grit, J ^a   Muller, M ^b   Postma, T J ^a   Mooij, J J ^c   Boerman, R H ^d   Beute, G N ^e   Ossenkoppele, G J ^a   Van Imhoff, G W ^c   Dekker, A W ^f   Jolles, J ^g   Slotman, B J ^a   Struikmans, H ^f   Taphoorn, M J B ^f  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CPRLab   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CANCER GRADING; CANCER RADIOTHERAPY; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; DRUG USE; FACTORIAL ANALYSIS; FEMALE; GLIOMA; HEMATOLOGIC DISEASE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL DEFICIENCY; NEUROSURGERY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RISK BENEFIT ANALYSIS; SELF REPORT; TIME; TREATMENT OUTCOME;

EID: 0037010410     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11398-5     Document Type: Article

References (31)

1. Van der Sanden G.A., Schouten L.J., van Dijck J.A., van Andel J.P., Coebergh J. Incidence of primary central nervous system cancers in South and East Netherlands in 1989-1994. Neuroepidemiology. 17:1998;247-257.
2. Recht L.D., Lew R., Smith T.W. Suspected low-grade glioma: is deferring treatment safe? Ann Neurol. 31:1992;431-436.
3. Bampoe J., Bernstein M. The role of surgery in low grade gliomas. J Neurooncol. 42:1999;259-269.
4. Bauman G., Pahapill P., Macdonald D., Fisher B., Leighton C., Cairncross G. Low grade glioma: a measuring radiographic response to radiotherapy. Can J Neurol Sci. 26:1999;18-22.
5. Shaw E.G. The low-grade glioma debate: evidence defending the position of early radiation therapy. Clin Neurosurg. 42:1995;488-494.
6. Philippon J.H., Clemenceau S.H., Fauchon F.H., Foncin J.F. Supratentorial low-grade astrocytomas in adults. Neurosurgery. 32:1993;554-559.
7. Kiebert G.M., Curran D., Aaronson N.K., et al. Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC Trial 22844). Eur J Cancer. 34:1998;1902-1909.
8. Karim A.B., Afra D., Cornu P., et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organisation for Research and Treatment of Cancer study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys. 52:2002;316-324.
9. Crossen J.R., Garwood D., Glatstein E., Neuwelt E.A. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol. 12:1994;627-642.
10. Surma-aho O., Niemela M., Vilkki J., et al. Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology. 56:2001;1285-1290.
11. DeAngelis L.M., Delattre J.Y., Posner J.B. Radiation-induced dementia in patients cured of brain metastases. Neurology. 39:1989;789-796.
12. Abrey L.E., DeAngelis L.M., Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol. 16:1998;859-863.
13. Leighton C., Fisher B., Bauman G., et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol. 15:1997;1294-1301.
14. Olson J.D., Riedel E., DeAngelis L.M. Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology. 54:2000;1442-1448.
15. Taphoorn M.J., Schiphorst A.K., Snoek F.J., et al. Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol. 36:1994;48-54.
16. Classification, assessment, surveys, and terminology team. International Classification of Functioning, Disability and Health (ICIDH-2). Geneva: World Health Organization, 2001.
17. Cull A., Hay C., Love S.B., Mackie M., Smets E., Stewart M. What do cancer patients mean when they complain of concentration and memory problems? Br J Cancer. 74:1996;1674-1679.
18. Van Boxtel M.P.J., Buntinx F., Houx P.J., Metsemakers J.F.M., Knottnerus A., Jolles J. The relation between morbidity and cognitive performance in a normal aging population. J Gerontol. 53A:1998;M147-M154.
19. Karnofsky D.A., Abelmann W.H., Craver L.F. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer. 1:1948;634-656.
20. Wade D.T., Collin C. The Barthel ADL index: a standard measure of physical disability? Int Disabil Stud. 10:1988;64-67.
21. Order S., Hellman S., Von Essen C., Kligerman M.M. Improvement in quality of survival following whole-brain irradiation for brain metastasis. Radiology. 91:1968;149-153.
22. Schmand B., Bakker D., Saan R., Louman J. The Dutch reading test for adults: a measure of premorbid intelligence level. Tijdschr Gerontol Geriatr. 22:1991;15-19.
23. Lezak M.D. Neuropsychological assessment. 3rd edn:1995;Oxford University Press, New York.
24. Houx P.J., Jolles J. Vulnerability factors for age-related cognitive decline. Isaacson R.L., Jensen K.F., The vulnerable brain and environmental risks. 1994;25-41 Plenum Press, New York.
25. Van Dam F.S., Schagen S.B., Muller M.J., et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst. 90:1998;210-218.
26. Stewart A.L., Ware J.E., Measuring functioning and well-being: the medical outcomes study approach. 1992;Duke University Press, Durham, NC.
27. Corn B.W., Yousem D.M., Scott C.B., et al. White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02). Cancer. 74:1994;2828-2835.
28. Postma T.J., Klein M., Verstappen C.C.P., et al. Radiotherapy-induced cerebral abnormalities in low-grade glioma patients. Neurology. 59:2002;121-130.
29. Anderson S.W., Damasio H., Tranel D. Neuropsychological impairments associated with lesions caused by tumor or stroke. Arch Neurol. 47:1990;397-405.
30. Taphoorn M.J., Heimans J.J., Snoek F.J., et al. Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry. 55:1992;372-376.
31. Klein M., Houx P.J., Jolles J. Long-term persisting cognitive sequelae of traumatic brain injury and the effect of age. J Nerv Ment Dis. 184:1996;459-467.